Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapseMark J. Levis, B. Douglas Smith, Farhad Ravandi et al.|Blood|2011Cited by 402
Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium studyJane E. Minturn, John M. Maris, Susan Groshen et al.|Cancer Chemotherapy and Pharmacology|2011Cited by 98
Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse.Mark J. Levis, B. Douglas Smith, Farhad Ravandi et al.|Blood|2009Cited by 32